Breaking News

Sosei, FUJIFILM Pharma Sign Distribution Pact

Sosei to manufacture and supply antifungal agent

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sosei Group’s Japanese subsidiary, Sosei Co., Ltd., has signed a distribution agreement with FUJIFILM Pharma Co., Ltd for the commercialization of SO-1105 in Japan. SO-1105 is an antifungal agent, administered as a muco-adhesive buccal tablet for the treatment of oropharyngeal candidiasis in immunocompromised patients. The drug is currently registered in 24 European countries, in South Korea, and in the U.S., under the trade names Loramyc/Oravig. Sosei acquired exclusive development and commerci...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters